ADCT peer analysis
ADC Therapeutics (ADCT) against its competitors: price, today's move, 1-year return and market value side by side.
- ADCT's peers: ALMS (Alumis), AUTL (Autolus Therapeutics), BCYC (Bicycle Therapeutics), FDMT (4D Molecular), LCTX (Lineage Cell Therapeutics), LXRX (Lexicon Pharmaceuticals), NMRA (Neumora Therapeutics), OMER (Omeros).
ADCT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALMS Alumis | $4.03 | -6.93% | -38.66% | $523.18M |
| AUTL Autolus Therapeutics | $0.92 | -6.08% | -27.56% | $245.03M |
| BCYC Bicycle Therapeutics | $2.90 | -4.92% | -53.60% | $203.27M |
| FDMT 4D Molecular | $10.23 | -4.57% | -5.28% | $740.49M |
| LCTX Lineage Cell Therapeutics | $0.83 | 0.76% | -51.68% | $208.99M |
| LXRX Lexicon Pharmaceuticals | $1.50 | -10.03% | 3.62% | $668.96M |
| NMRA Neumora Therapeutics | $0.35 | -5.40% | -86.34% | $65.48M |
| OMER Omeros | $13.19 | -5.85% | 60.46% | $982.17M |
| QSI Quantum-Si | $0.93 | -13.09% | -27.35% | $204.34M |
| ADCT ADC Therapeutics | $1.28 | -1.54% | -68.16% | $180.05M |